NRx Pharmaceuticals Inc. (NRXP)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
4.47
-0.63 (-12.35%)
At close: Jan 15, 2025, 12:51 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
PE Ratio | -1.16 | -20.72 | -31.27 | -677.26 | 132.06 | 1.38K | -83.27 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -2.97 | 98.53 | 107.79 | -191.04 | 1.83 | 1.31 | 0.13 |
P/FCF Ratio | -1.61 | -18.36 | -59.47 | -3.69K | -68.04 | -192.39 | -64.4 |
P/OCF Ratio | -1.61 | -18.36 | -59.48 | -3.69K | -68.04 | -192.39 | -64.4 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -0.78 | 1.42 | 0.02 | -0.02 | 0.07 | 0.01 | n/a |
Quick Ratio | 0.36 | 1.56 | 2.74 | 0.06 | 0.11 | 0.05 | 5.76 |
Current Ratio | 0.36 | 1.56 | 2.74 | 0.06 | 0.11 | 0.05 | 5.76 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -229.89 | n/a | -6.43K | -917.63 | n/a | n/a | n/a |
Return on Equity (ROE) | 2.57 | -4.76 | -3.45 | 0.28 | 0.01 | 0.00 | -0.00 |
Return on Assets (ROA) | -4.12 | -1.36 | -2.19 | -4.2 | 0.01 | 0.00 | -0.00 |
Return on Capital (ROIC) | 2.35 | -4.81 | -5.57 | 1.19 | -0.00 | -0.01 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |